Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

Beijing Hotgen Biotech Revenue

Beijing Hotgen Biotech had revenue of 93.24M CNY in the quarter ending March 31, 2025, a decrease of -19.71%. This brings the company's revenue in the last twelve months to 488.01M, up 7.39% year-over-year. In the year 2024, Beijing Hotgen Biotech had annual revenue of 510.89M, down -5.61%.

• Revenue (ttm): 488.01M
• Revenue Growth: +7.39%
• P/S Ratio: 24.76
• Revenue / Employee: n/a
• Employees: 1,036
• Market Cap: 12.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	510.89M	-30.36M	-5.61%
Dec 31, 2023	541.25M	-3.02B	-84.78%
Dec 31, 2022	3.56B	-1.81B	-33.76%
Dec 31, 2021	5.37B	4.86B	945.54%
Dec 31, 2020	513.53M	303.12M	144.06%